Back Login to subscribe 🔔 Set Alert

SLBT SL Science Holding Limited Ordinary Shares

15 min delay

Loading...

Loading...

Loading...

Loading options…

CALLS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

PUTS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

Loading insider data…

Date	Headline	Sentiment
	SL Science Presents Benefits Of Gamma Delta T Cells In Eliminating Glioblastoma In Preclinical Studies At The 2026 World Congress Of Basic And Clinical Pharmacology	82.54%
	Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session	97.26%
	SL Science Holding shares are trading higher after the company announced it has submitted an Orphan Drug Designation request to the FDA for its Gamma Delta T cell therapy product, Vdelta2+ Gamma Delta T Cells, for the treatment of glioblastoma multiforme.	94.8%
	SL Science Submits Orphan Drug Designation Request To FDA For Gamma Delta T Cell Therapy Product, Vdelta2+ Gamma Delta T Cells, For Treatment Of Glioblastoma Multiforme	57.03%
	12 Health Care Stocks Moving In Monday's Intraday Session	96.2%
	Why Maison Solutions Shares Are Trading Higher By Over 62%; Here Are 20 Stocks Moving Premarket	86.53%
	12 Health Care Stocks Moving In Thursday's After-Market Session	96.82%
	11 Health Care Stocks Moving In Thursday's Intraday Session	89.93%
	12 Health Care Stocks Moving In Wednesday's Intraday Session	95.02%